Open, Single-dose/-Period Study to Assess Mass Balance Recovery, Metabolite Profile/Identification of 14C-Varlitinib
Clinical trial NCT03368846 · COMPLETED
Trial details
- NCT number
- NCT03368846
- Sponsor
- ASLAN Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-23
- Primary completion
- 2017-12-06
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.